semaglutide court ruling US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Novo Nordisk wins positive ruling

Key Strains Table Key Takeaway: Look for a multi-strain probiotic that includes both Lactobacillus and Bifidobacterium families to provide the most comprehensive support for the slowed gastric emptying associated with GLP-1 therapy

March 9, 2026 Deal with Novo Nordisk: In a significant pivot, Novo Nordisk and Hims & Hers announced an agreement on March 9, 2026, to offer various doses of Ozempic through the Hims platform for direct-to-consumer customers, effectively moving Hims away from compounded semaglutide toward branded, FDA-approved medication access

Shipping was fast and vials were well packed

Pasqualini L, Bu H, Puhr M, Narisu N, Rainer J, Schlick B, Schfer G, Angelova M, Trajanoski Z, Brno ST